Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Green synthesis of upconversion nanocrystals by adjusting local precursor supersaturation under aqueous conditions

Su Li a, Jie Chen b, Yu Ying Tang a, Lin Yu Hu a, Wen Hui Qian a, Dong Zhu *ab and Peng Chen *b
aSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P. R. China. E-mail: dongzhu@njucm.edu.cn
bSchool of Chemical and Biomedical Engineering, Nanyang Technological University, 637457, Singapore. E-mail: chenpeng@ntu.edu.sg

Received 5th August 2020 , Accepted 13th September 2020

First published on 15th September 2020


Abstract

We describe a green synthesis of upconversion nanocrystals (UCNs) by adjusting local precursor supersaturation under aqueous conditions at low temperature with size and phase control as well as high production yield. The synthesis allows the separation of nucleation and growth, leading to the formation of small UCNs with a uniform size. Ultra-small α-phase UCNs (∼6.3 nm) and bright β-phase UCNs (∼25.5 nm) have been synthesized.


Upconversion nanocrystals (UCNs) have wide-spread applications in imaging and sensing,1–4 solar cells,5 displays,6 encryption7,8 and photothermal therapy9 because of their charming features including multicolored emissions, excellent photostability, and the capability to be excited by near-infrared (NIR).10 The last feature is particularly beneficial for photo-theranostics due to reduced auto-fluorescence, tissue damage and enhanced penetration depth.11 NaYF4:Yb3+,Tm3+ nanocrystals are paid special attention, not only because NaYF4 is an efficient host material for upconversion emission,12 but also because its excitation at 980 nm and upconversion emission around 800 nm are within the spectral scope recognized as the ‘window of optical transparency’ for biological tissues.13

Current synthesis methods for UCNs, however, usually suffer from the requirements for high temperature in the presence of high-boiling point organic solvents, long reaction time, surfactants, expensive and unstable precursors, or tedious procedures. These syntheses often are of low-yield and high-cost, and produce environmental hazards. The biological applications demand small-sized UCNs (<10 nm) to ensure thorough and fast clearance from the body.14–19 But synthesis of ultra-small and uniform UCNs remains as a great difficulty. Synthesis of bright NIR-emitting UCNs for in vivo imaging is also challenging. UCNs may exist in either cubic (α) or hexagonal (β) phase. The α phase is metastable whilst the β phase, which gives enhanced UC emission, is thermodynamically stable. Transition from α to β phase, however, demands high reaction temperature of 300–320 °C in organic solvent and prolonged reaction time (even up to several days).20–29

In this contribution, we have developed a green strategy by adjusting local precursor supersaturation to synthesize uniform UCNs with high yield under mild aqueous conditions. The use of fatty acids as the chelating ligands for rare earth ions and as a stabilizer for UCNs reduces the energy barrier for nucleation and transition from α to β phase. Through rational designs, ultra-small α-UCNs (<7 nm) and bright β-UCNs (∼25 nm) emitting at 800 nm are obtained.

For current synthesis methods, constant nuleation occurs concomitantly with nanocrystal growth because the reaction has to start with a concentration higher than needed for growth in order to initiate nucleation.29 Some hydrothermal syntheses also provide a liquid nucleation model30 or liquid–solid-solution phase transfer strategy.31 Consequently, the produced nanoparticles are highly heterogeneous in size. To tackle this dilemma, we developed a strategy by adjusting the local precursor supersaturation to synthesize NaYF4:Yb3+,Tm3+ nanocrystals as shown in Fig. 1.


image file: d0ma00568a-f1.tif
Fig. 1 Schematic illustration of green synthesis for UCNs.

Sodium oleate molecules (18 carbon fatty acid) were firstly diserpsed in aqueous solution. When rare earth (RE) ions are added with much lower abundance as compared to oleate, they are completely chelated by the carboxyl groups on the oleate molecules leading to the formation of aggregates ∼1000 nm in size (Fig. S2 in the ESI) because of charge neutralization. As a consequence, the local concentration of RE ions at the interface between aggregates is increased to exceed Sn (whereby it reduces ΔGv). The subsequent addition of F ions triggers the nucleation of UCNs while some oleate molecules remain on the surface to lower the surface energy (ΔGs). The appearance of the two wide peaks in the X-ray diffraction (XRD) pattern corresponding to the 111 and 220 planes of α-phase nanocrystals indicates the formation of small nuclei of UCNs (Fig. S3a in the ESI).

Taken together, the nucleation process at the ambient temperature is favored in this system due to lowered ΔG even when the bulk concentrations of the precursor ions are low. At an increased temperature (120 °C), the growth of UCNs occurs at the aggregate interface and is sustained by surrounding chelated RE ions on interfacing aggregates. The size of the finally obtained UCNs is confined by the restricted supply of RE ions. As revealed by transmission electron microscopy (TEM), UCNs (3 h growth) show good monodispersity with the average size of ∼6.3 ± 0.3 nm (100 samples) (Fig. S3b in the ESI). In agreement with our hypothesis, prolonged reaction (8 h) doesn’t significantly increase the UCN size (∼6.6 ± 0.3 nm, 100 samples) further (Fig. 2a). The XRD peaks of the obtained nanoparticles are in accordance with that from α-UCNs (Fig. S4a in the ESI). In summary, because faciliated nucleation at ambient temperature and growth at high temperature with restricted supply of RE ions are separated in this synthesis, the resulting UCNs are small and uniform.


image file: d0ma00568a-f2.tif
Fig. 2 TEM images of the UCNs synthesized using (a) sodium oleate, (b) sodium oatanoate and (c) sodium acrylate under 120 °C hydrothermal conditions for 8 h. Insets show the size distribution. (d) UCN size versus the carbochain length of the used fatty acid. TEM images of the UCNs synthesized using sodium oleate under (e) 150 °C, (f) 170 °C and (g) 200 °C for 8 h. Insets present HRTEM images. (h) UCN size versus the reaction temperature. (i) TEM image of the prepared UCNs with the F/Y3+ molar ratio of 32 (7 h reaction at 150 °C).

As shown in Fig. 2b and c, when sodium acrylate (3 carbon fatty acid) or sodium oatanoate (8 carbon fatty acid) is used as the chelator of RE ions and stabilizer of UCNs, the same synthesis produces much larger α-UCNs with wide size distribution (∼56.2 ± 16.3 nm, 100 samples; ∼15.5 ± 1.5 nm, 100 samples). This is because these two fatty acids within (RE) ions cannot form aggregates (Fig. S5a and b in the ESI) and therefore are not able to assist nucleation at ambient temperature (TEM not shown). The UCNs obtained from sodium oatanoate are relatively small conceivably because the fatty acid chains on the UCN surface limit the growth rate by restricting the diffusion of RE ions in the solution to the nucleation core. As evidenced by Fig. 2d, we propose that the size of UCNs can be controlled by the chain length of the used fatty acid.

The small-sized UCNs are particularly attractive for in vivo applications. Our α-phase NaYF4:Yb3+,Tm3+ nanocrystal is the smallest UCN using NaYF4 as the host material.19–21 Thus far, the demonstration of ultrasmall UCNs is still limited, and they are all synthesized in an organic medium at high temperature (>300 °C) with moderate production yield.15,24–27 Using our methods, a high yield of ∼86% with a very low concentration of Y3+ (6.4 mM which is an order lower than typically needed) is obtained.15

The size of UCNs increases with the increasing reaction temperature (Fig. 2e–g) presumably because a higher temperature makes the chelated Y3+ ions become more mobile in the aggregates. The characteristic lattice spacing resolved by high-resolution TEM (HRTEM) indicates that UCNs obtained at 120, 150, and 170 °C are α-phase while 200 °C produces β-UCNs.

XRD characterization also confirms their phase identity (Fig. 3a). Under 200 °C, 1 h reaction yields α-UCNs only; 3 h reaction gives a mixture of α- and β-UCNs; 5 h and above produce only β-UCNs (Fig. 3b). As expected, increasing temperature and reaction time favors the transition from α to β phase. Notably, α to β phase transition doesn’t occur under the same conditions when sodium acrylate or sodium oatanoate are used (Fig. S4b in the ESI). This implies that aggregate-assisted nucleation is more thermodynamically stable and favors the phase transition.


image file: d0ma00568a-f3.tif
Fig. 3 (a) XRD spectra of the UCNs obtained at different reaction temperatures for 8 h. PDF (no. 01-077-2042) of cubic α-phase and PDF (no. 00-016-0334) of hexagonal β-phase NaYF4 are indicated at the top and bottom axis, respectively. (b) XRD spectra of the UCNs prepared using different reaction durations at 200 °C. (c) XRD spectra of the UCNs prepared at 150 °C for 7 h with different F to Y3+ molar ratios.

The previous studies have demonstrated that increasing the F to Y3+ ratio promotes α to β phase transition,20 because excessive F ions passivate the dangling bonds on UCN thereby reducing the surface energy of the nanoparticle. With F to Y3+ ratio of 32 (Y3+ reduced from 26.4 mM to 6.6 mM while F being increased from 108 mM to 216 mM), the reaction time for phase transition at 200 °C is largely decreased from 5 h to 1 h (Fig. S4c in the ESI). But the reaction at such high temperature leads to heterogeneous distribution of the produced nanoparticles.

Fig. 3c demonstrates that α to β transformation can occur at 150 °C with F to Y3+ ratio of 32 when the reaction time is increased to 7 h. As uncovered by TEM (Fig. 2i), the obtained β-UCNs have uniform size distribution (25.5 ± 0.3 nm, 100 samples). The size uniformity is attributable to the low reaction temperature as well as aggregate-controlled growth by adjusting local precursor supersaturation. TEM imaging shows that the formed β-UCNs are surrounded by aggregates (Fig. S4d in the ESI). Reducing the F to Y3+ ratio fails to produce β-UCNs under the same conditions (Fig. 3c). The previous synthesis methods for β-UCNs all require much higher temperature.20–29 And they often need long reaction time and sometimes produce large-sized particles.22–29

Under 980 nm laser excitation, the upconversion photoluminescence (UC PL) spectra of the β-phase NaYF4:Yb3+,Tm3+ nanocrystals prepared at 150 °C exhibit two prominent peaks around 475 nm and 800 nm, which resulted from 1G43H6 and 3H43H6 transitions of Tm3+ ions, respectively (Fig. 4a). Under 0.5 W laser, the nanocrystal solution (5 mg mL−1) appears bright blue (Fig. 4b), indicating its high quantum yield. Subjected to the same excitation at 980 nm, the emission peak of our UCNs at NIR (800 nm) is ∼2.3 times that from a commercial green UCN (Sigma-Aldrich, NaYF4:Yb3+,Er3+).


image file: d0ma00568a-f4.tif
Fig. 4 (a) UC PL spectra of the prepared β-phase NaYF4:Yb3+,Tm3+ nanocrystals (1 mg mL−1) and the commercial upconversion NaYF4:Yb3+,Er3+ nanocrystals (Sigma) (1mg mL−1) under 980 nm laser excitation with 0.5 W. (b) The photographic image of the β-phase nanocrystal solution without and with laser excitation at 980 nm. (c) UC PL spectra of the prepared NaYF4:Yb3+,Er3+ nanocrystals under laser excitation at 980 nm. (d) The photographic image of β-phase NaYF4:Yb3+,Er3+ nanocrystal solutions without and with laser excitation at 980 nm.

To demonstrate the versatility of our approach, we synthesized another class of upconversion nanocrystals, namely, NaYF4:Yb3+,Er3+. Fig. S6a and b (ESI) present the representative TEM images of α-phase and β-phase NaYF4:Yb3+,Er3+ nanocrystals, respectively. The strong emission around 542 nm and 654 nm from the β-phase UCN are originated from 4S3/24I15/2 and 4F9/24I15/2 transition of Er3+ (Fig. 4c and d). Weak acid treatment to remove oleate and the conjugating poly (acrylic acid) (PAA) on the UCN under solvothermal conditions renders the nanocrystals water soluble for bio-applications (Fig. 1). Using Fourier-transform infrared spectroscopy (FTIR), the success of PAA attachment is confirmed by the vibration peak (3468 cm−1) of C–H bond and the vibration peak (1642 cm−1) of C[double bond, length as m-dash]O from PAA (Fig. S7 in the ESI).

Conclusions

In summary, a new green method to synthesize upconversion nanocrystals (UCNs) with high production yield at low temperature has been demonstrated. Fatty acids are used as the chelator for rare earth ions and stabilizer of UCNs, allowing the synthesis to occur under aqueous conditions. Aggregates formed by fatty acids facilitate the nucleation at low temperature by adjusting the local precursor supersaturation. And such a synthesis allows separation of nucleation and growth, leading to formation of ultrasmall α-phase UCNs with uniform size distribution (∼6.3 nm). The particle size can be tuned by choosing fatty acids with different carbon chain lengths. And at moderately increased temperature, α to β phase transition can occur producing bright NIR-emitting UCNs. In principle, other aggeregates forming molecules other than fatty acids may also be used and the same strategy may also be applied for high quality synthesis of other nanocrystals.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This work was financially supported by an AcRF tier 2 grant (MOE2017-T2-2-005) from the Ministry of Education (Singapore). We sincerely appreciate the National Natural Science Foundation of China for the financial support (81573388). This work was supported by “Qing Lan Project of Jiangsu Province” and “Six Talent Peaks Project of Jiangsu Province (YY-032)”. This work was also supported by the Open Project Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica (No. JKLPSE201805).

Notes and references

  1. D. Vennerberg and Z. Lin, Sci. Adv. Mater., 2011, 3, 26–40 Search PubMed.
  2. H. Wen, H. Zhu, X. Chen, T. F. Hung, B. Wang, G. Zhu, S. F. Yu and F. Wang, Angew. Chem., Int. Ed., 2013, 52, 13419–13423 Search PubMed.
  3. H. Wen, H. Zhu, X. Chen, T. F. Hung, B. Wang, G. Zhu, S. F. Yu and F. Wang, Angew. Chem., Int. Ed., 2013, 125, 13661–13665 Search PubMed.
  4. D. K. Chatterjee, M. K. Gnanasammandhan and Y. Zhang, Small, 2010, 6, 2781–2795 Search PubMed.
  5. (a) A. D. Ostrowski, E. M. Chan, D. J. Gargas, E. M. Katz, G. Han, P. J. Schuck, D. J. Milliron and B. E. Cohen, ACS Nano, 2012, 6, 2686–2692 Search PubMed; (b) T. Rinkel, J. Nordmann, A. N. Raj and M. Haase, Nanoscale, 2014, 6, 14523–14530 Search PubMed.
  6. (a) C. Zhang, H. P. Zhou, L. Y. Liao, W. Feng, W. Sun, Z. X. Li, C. H. Xu, C. J. Fang, L. D. Sun and Y. W. Zhang, Adv. Mater., 2010, 22, 633–637 Search PubMed; (b) R. Deng, F. Qin, R. Chen, W. Huang, M. Hong and X. Liu, Nat. Nanotechnol., 2015, 10, 237–242 Search PubMed.
  7. (a) H. H. Gorris and O. S. Wolfbeis, Angew. Chem., Int. Ed., 2013, 52, 3584–3600 Search PubMed; (b) J. Lee, P. W. Bisso, R. L. Srinivas, J. J. Kim, A. J. Swiston and P. S. Doyle, Nat. Mater., 2014, 13, 524–529 Search PubMed.
  8. Y. Lu, J. Lu, J. Zhao, J. Cusido, F. M. Raymo, J. Yuan, S. Yang, R. C. Leif, Y. Huo, J. A. Piper, J. Paul Robinson, E. M. Goldys and D. Jin, Nat. Commun., 2014, 5, 3741 Search PubMed.
  9. (a) P. Zhang, P. Steelant, M. Kumar and M. Scholfield, J. Am. Chem. Soc., 2007, 129, 4526–4527 Search PubMed; (b) F. Wang, D. Banerjee, Y. Liu, X. Chen and X. Liu, Analyst, 2010, 135, 1839–1854 Search PubMed.
  10. (a) F. Wang and X. G. Liu, J. Am. Chem. Soc., 2008, 130, 5642–5643 Search PubMed; (b) S. W. Wu, G. Han, D. J. Milliron, S. Aloni, V. Altoe, D. V. Talapin, B. E. Cohen and P. J. Schuck, Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 10917–10921 Search PubMed; (c) M. X. Yu, F. Y. Li, Z. G. Chen, H. Hu, C. Zhan and C. H. Huang, Anal. Chem., 2009, 81, 930 Search PubMed.
  11. (a) G. Jalani, R. Naccache, D. H. Rosenzweig, L. Haglund, F. Vetrone and M. Cerruti, J. Am. Chem. Soc., 2016, 138(3), 1078–1083 Search PubMed; (b) L. Q. Xiong, Z. G. Chen, Q. W. Tian, T. Y. Cao, C. J. Xu and F. Y. Li, Anal. Chem., 2009, 81, 8687 Search PubMed.
  12. J. C. Boyer, M. P. Manseau, J. L. Murray and F. C. J. M. van Veggel, Langmuir, 2010, 26, 1157 Search PubMed.
  13. M. Nyk, R. Kumar, T. Y. Ohulchanskyy, E. J. Bergey and P. N. Prasad, Nano Lett., 2008, 8, 3834–3838 Search PubMed.
  14. H. S. Choi, W. Liu, P. Misra, E. Tanaka, J. P. Zimmer, B. I. Ipe, M. G. Bawendi and J. V. Frangioni, Nat. Biotechnol., 2007, 25, 1165 Search PubMed.
  15. G. Y. Chen, H. L. Qiu, P. N. Prasad and X. Y. Chen, Chem. Rev., 2014, 114, 5161–5214 Search PubMed.
  16. A. N. Raj, T. Rinkel and M. Haase, Chem. Mater., 2014, 26, 5689–5694 Search PubMed.
  17. N. J. J. Johnson, W. Oakden, G. J. Stanisz, R. S. Prosser and F. C. J. M. van Veggel, Chem. Mater., 2011, 23, 3714–3722 Search PubMed.
  18. B. Voß, J. Nordmann, A. Uhl, R. Komban and M. Haase, Nanoscale, 2013, 5, 806–812 Search PubMed.
  19. Q. Liu, Y. Sun, T. S. Yang, W. Feng, C. G. Li and F. Y. Li, J. Am. Chem. Soc., 2011, 133, 17122–17125 Search PubMed.
  20. T. Rinkel, A. N. Raj, S. Dîhnen and M. Haase, Angew. Chem., Int. Ed., 2016, 55, 1164–1167 Search PubMed.
  21. G. Y. Chen, T. Y. Ohulchanskyy, R. Kumar, H. Ågren and P. N. Prasad, ACS Nano, 2010, 4(6), 3163–3168 Search PubMed.
  22. (a) M. Sindoro, N. Yanai, A. Y. Jee and S. Granick, Acc. Chem. Res., 2014, 47, 459–469 Search PubMed; (b) X. G. Wang, Q. Cheng, Y. Yu and X. Z. Zhang, Angew. Chem., 2018, 130, 7962–7966 Search PubMed.
  23. L. Y. Pan, M. He, J. B. Ma, W. Tang, G. Gao, R. He, H. C. Su and D. X. Cui, Theranostics, 2013, 3(3), 210–222 Search PubMed.
  24. C. Burda, X. B. Chen, R. Narayanan and M. A. El-Sayed, Chem. Rev., 2005, 105, 1025–1102 Search PubMed.
  25. (a) B. L. Cushing, V. L. Kolesnichenko and C. J. O’Connor, Chem. Rev., 2004, 104, 3893–3946 Search PubMed; (b) J. C. Boyer, L. A. Cuccia and J. A. Capobianco, Nano Lett., 2007, 7, 847–852 Search PubMed.
  26. X. Liang, X. Wang, J. Zhuang, Q. Peng and Y. D. Li, Adv. Funct. Mater., 2007, 17, 2757–2765 Search PubMed.
  27. F. Wang, Y. Han, C. S. Lim, Y. Lu, J. Wang, J. Xu, H. Chen, C. Zhang, M. Hong and X. Liu, Nature, 2010, 463, 1061–1065 Search PubMed.
  28. D. J. Gargas, E. M. Chan, A. D. Ostrowski, S. Aloni, M. V. P. Altoe, E. S. Barnard, B. Sanii, J. J. Urban, D. J. Milliron, B. E. Cohen and P. J. Schuck, Nat. Nanotechnol., 2014, 9, 300–305 Search PubMed.
  29. F. Shi and Y. Zhao, J. Mater. Chem. C, 2014, 2, 2198–2203 Search PubMed.
  30. S. H. Feng and R. R. Xu, Acc. Chem. Res., 2001, 34, 239–247 Search PubMed.
  31. X. Wang and Y. Li, Chem. Commun., 2007, 2901–2910 Search PubMed.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/d0ma00568a

This journal is © The Royal Society of Chemistry 2020
Click here to see how this site uses Cookies. View our privacy policy here.